Stockreport

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

Zevra Therapeutics, Inc.  (ZVRA) 
PDF BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies [Read more]